References
- Ahlneck C., Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 1990; 62: 87–95
- Badawy S. I.F., Williams R. C., Gilbert D. L. Effect of different acids on solid state stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist. Pharm. Dev. Technol. 1999; 4(3)325–331
- Zografi G., Kontny M. J. The interaction of water with cellulose‐ and starch‐derived pharmaceutical excipients. Pharm. Res. 1986; 3: 187–194
- Kallion R. B., Stella V. J. The nucleophilicity of dextrose, sucrose, sorbitol, and mannitol with p‐nitrophenyl esters in aqueous solutions. Int. J. Pharm. 1990; 66: 149–155
- Badawy S. I.F., Williams R. C., Gilbert D. L. Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms. J. Pharm. Sci. 1999; 88(4)428–433
- Brandl M., Magill A., Rudraraju V., Gordon M. S. Approaches for improving the stability of ketorolac in powder blends. J. Pharm. Sci. 1995; 84(10)1151–1153
- Gu L., Strickley R. G., Chi L. H., Chowhan Z. T. Drug‐excipient incompatibility studies of the dipeptide angiotensin‐converting enzyme inhibitor, moexipril hydrochloride: dry powder vs. wet granulation. Pharm. Res. 1990; 7(4)379–383
- Irwin W. J., Iqbal M. Solid‐state stability: the effect of grinding solvated excipients. Int. J. Pharm. 1991; 75: 211–218
- Kitamura S., Miyamae A., Koda S., Morimoto Y. Effect of grinding on the solid‐state stability of cefixime trihydrate. Int. J. Pharm. 1989; 56: 125–134
- Waterman K. C., Adami R. C., Alsante K. M., Antipas A. S., Arenson D. R., Carrier R., Hong J., Landis M. S., Lombardo F., Shah J. C., Shalaev E., Smith S. W., Wang H. Hydrolysis in pharmaceutical formulations. Pharm. Dev. Technol. 2002; 7(2)113–146
- Shalaev E. Y., Zografi G. How does residual water affect the solid‐state degradation of drugs in the amorphous state?. J. Pharm. Sci. 1996; 85(11)1137–1141